Plasma semicarbazide-sensitive amine oxidase in human (patho)physiology

被引:96
作者
Boomsma, F [1 ]
Bhaggoe, UM [1 ]
van der Houwen, AMB [1 ]
van den Meiracker, AH [1 ]
机构
[1] Erasmus MC, Dept Internal Med, NL-3015 GD Rotterdam, Netherlands
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS | 2003年 / 1647卷 / 1-2期
关键词
amine oxidase; adhesion molecule; human plasma; vascular disease; diabetes; inflammation;
D O I
10.1016/S1570-9639(03)00047-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Semicarbazide-sensitive amine oxidases (SSAO) are widely distributed enzymes, with as yet not fully elucidated functions and roles, present in many tissues but also circulating in plasma. The enzyme also functions as an adhesion molecule, the vascular adhesion protein-1. In healthy humans, plasma SSAO activity is constant from birth until 16 years of age, when it drops to lower values, gradually increasing again at advanced ages. When measuring SSAO activity, care should be taken to ensure proper preparation and storage conditions, and it should be realized that quite a few drugs unintentionally are good inhibitors, and sometimes even substrates, of SSAO. Under normal conditions SSAO activity is constant and inter-individual variation is small. In various pathophysiological conditions plasma SSAO activities are increased, most notably in diabetes mellitus (both type I and type 11), in congestive heart failure and in cirrhotic liver inflammation. In patients with other vascular and inflammatory diseases plasma SSAO is normal, while it is low in children with congenital lung diseases. Interpretation of these changes is speculative, since source and regulation of plasma SSAO are as yet unknown. However, in two situations where the disease-causing process was ended (transplantation, delivery), plasma SSAO returned to normal. Many questions remain to be answered. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:48 / 54
页数:7
相关论文
共 40 条
  • [1] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF SERUM ALIPHATIC-AMINES IN CHRONIC-RENAL-FAILURE
    BABA, S
    WATANABE, Y
    GEJYO, F
    ARAKAWA, M
    [J]. CLINICA CHIMICA ACTA, 1984, 136 (01) : 49 - 56
  • [2] BERGQUIST M, 2000, P 9 INT AM OX WORKSH, P88
  • [3] Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure
    Boomsma, F
    vanVeldhuisen, DJ
    deKam, PJ
    ManintVeld, AJ
    Mosterd, A
    Lie, KI
    Schalekamp, MADH
    [J]. CARDIOVASCULAR RESEARCH, 1997, 33 (02) : 387 - 391
  • [4] PLASMA SEMICARBAZIDE-SENSITIVE AMINE OXIDASE ACTIVITY IS ELEVATED IN DIABETES-MELLITUS AND CORRELATES WITH GLYCOSYLATED HEMOGLOBIN
    BOOMSMA, F
    DERKX, FHM
    VANDENMEIRACKER, AH
    MANINTVELD, AJ
    SCHALEKAMP, MADH
    [J]. CLINICAL SCIENCE, 1995, 88 (06) : 675 - 679
  • [5] Plasma semicarbazide-sensitive amine oxidase (SSAO) is an independent prognostic marker for mortality in chronic heart failure
    Boomsma, F
    De Kam, PJ
    Tjeerdsma, G
    Van Den Meiracker, AH
    Van Veldhuisen, DJ
    [J]. EUROPEAN HEART JOURNAL, 2000, 21 (22) : 1859 - 1863
  • [6] Boomsma F., 2000, Neurobiology (Budapest), V8, P1
  • [7] Circulating semicarbazide-sensitive amine oxidase is raised both in Type I (insulin-dependent), in Type II (non-insulin-dependent) diabetes mellitus and even in childhood Type I diabetes at first clinical diagnosis
    Boomsma, F
    van den Meiracker, AH
    Winkel, S
    Aanstoot, HJ
    Batstra, MR
    in't Veld, AJM
    Bruining, GJ
    [J]. DIABETOLOGIA, 1999, 42 (02) : 233 - 237
  • [8] CONTRASTING EFFECTS OF PERIPHERAL DECARBOXYLASE INHIBITORS ON PLASMA ACTIVITY OF AROMATIC-L-AMINO ACID DECARBOXYLASE AND SEMICARBAZIDE-SENSITIVE AMINE OXIDASE IN PARKINSONS-DISEASE
    BOOMSMA, F
    VANDENMEIRACKER, A
    MANINTVELD, A
    SCHALEKAMP, M
    [J]. LIFE SCIENCES, 1995, 57 (19) : 1753 - 1759
  • [9] Boomsma F, 2001, DIABETOLOGIA, V44, P388
  • [10] Variation in semicarbazide-sensitive amine oxidase activity in plasma and tissues of mammals
    Boomsma, F
    van Dijk, J
    Bhaggoe, UM
    Bouhuizen, AMB
    van den Meiracker, AH
    [J]. COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 2000, 126 (01): : 69 - 78